Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN103396426B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103396426B reveals novel NHC-Cu catalysis for chiral boronic acids. Enhances purity and reduces manufacturing costs for reliable pharmaceutical intermediate supply chains.
Patent CN103396426B reveals novel NHC-catalyzed synthesis. Enhances yield and stereoselectivity for diabetes and tumor drug intermediates.